Paul Blaker

801 total citations
29 papers, 588 citations indexed

About

Paul Blaker is a scholar working on Public Health, Environmental and Occupational Health, Genetics and Epidemiology. According to data from OpenAlex, Paul Blaker has authored 29 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Public Health, Environmental and Occupational Health, 13 papers in Genetics and 9 papers in Epidemiology. Recurrent topics in Paul Blaker's work include Acute Lymphoblastic Leukemia research (14 papers), Inflammatory Bowel Disease (13 papers) and Microscopic Colitis (8 papers). Paul Blaker is often cited by papers focused on Acute Lymphoblastic Leukemia research (14 papers), Inflammatory Bowel Disease (13 papers) and Microscopic Colitis (8 papers). Paul Blaker collaborates with scholars based in United Kingdom, Australia and Norway. Paul Blaker's co-authors include Anthony M. Marinaki, Jeremy Sanderson, Raju Kapoor, Meirion Davies, Susan Hall, Kenneth J. Smith, Peter M. Irving, Melissa Smith, Monica Arenas-Hernandez and Simon H. Anderson and has published in prestigious journals such as Gastroenterology, Annals of Neurology and Gut.

In The Last Decade

Paul Blaker

28 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Blaker United Kingdom 11 259 229 122 113 74 29 588
ANNE M. V. BROOKS Australia 20 207 0.8× 46 0.2× 62 0.5× 153 1.4× 123 1.7× 84 1.2k
Gary Tye United States 13 53 0.2× 84 0.4× 69 0.6× 102 0.9× 178 2.4× 22 478
Amnon Cohen Italy 11 122 0.5× 147 0.6× 44 0.4× 28 0.2× 178 2.4× 16 745
M. P. Fondelli Italy 12 92 0.4× 41 0.2× 71 0.6× 37 0.3× 161 2.2× 28 624
L. Teerenhovi Finland 16 109 0.4× 113 0.5× 24 0.2× 189 1.7× 95 1.3× 29 747
N. Matheis Germany 14 101 0.4× 197 0.9× 33 0.3× 324 2.9× 87 1.2× 17 715
Haruo Tamaki Japan 15 97 0.4× 96 0.4× 41 0.3× 91 0.8× 69 0.9× 26 664
NORIO YOSHIKAWA Japan 16 34 0.1× 109 0.5× 84 0.7× 54 0.5× 104 1.4× 44 632
Hamed Esfandiari Iran 19 102 0.4× 55 0.2× 93 0.8× 82 0.7× 72 1.0× 89 980
N. Gombakis Greece 15 56 0.2× 31 0.1× 91 0.7× 24 0.2× 162 2.2× 40 577

Countries citing papers authored by Paul Blaker

Since Specialization
Citations

This map shows the geographic impact of Paul Blaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Blaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Blaker more than expected).

Fields of papers citing papers by Paul Blaker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Blaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Blaker. The network helps show where Paul Blaker may publish in the future.

Co-authorship network of co-authors of Paul Blaker

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Blaker. A scholar is included among the top collaborators of Paul Blaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Blaker. Paul Blaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Limdi, Jimmy K., Christian P. Selinger, Paul Blaker, et al.. (2021). A ‘real‐world’ retrospective multi‐centre cohort study comparing infliximab and adalimumab for the maintenance of remission in ulcerative colitis. 3(4). 229–235. 1 indexed citations
2.
Blaker, Paul, et al.. (2018). PTU-075 What is the benefit of telephone and virtual IBD clinics in a DGH?. A227.2–A229. 3 indexed citations
3.
4.
Ward, Mark G., Kamal Patel, Viraj C. Kariyawasam, et al.. (2016). Thioguanine in inflammatory bowel disease: Long‐term efficacy and safety. United European Gastroenterology Journal. 5(4). 563–570. 23 indexed citations
5.
Macken, Lucia & Paul Blaker. (2015). Management of acute severe ulcerative colitis (NICE CG 166). Clinical Medicine. 15(5). 473–476. 7 indexed citations
6.
Blaker, Paul, et al.. (2015). Getting the Best Out of Thiopurine Therapy: Thiopurine S -Methyltransferase and Beyond. Biomarkers in Medicine. 9(1). 51–65. 15 indexed citations
7.
Blaker, Paul, Viraj C. Kariyawasam, Kamal Patel, et al.. (2013). OC-015 The Influence of Gender and Haemoglobin on TPMT Activity. Gut. 62(Suppl 1). A6.3–A7. 2 indexed citations
8.
Blaker, Paul, Monica Arenas-Hernandez, Melissa Smith, et al.. (2013). Mechanism of allopurinol induced TPMT inhibition. Biochemical Pharmacology. 86(4). 539–547. 77 indexed citations
9.
10.
Smith, Melissa, Paul Blaker, Anthony M. Marinaki, et al.. (2012). Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol. Journal of Crohn s and Colitis. 6(9). 905–912. 76 indexed citations
11.
Blaker, Paul, Mónica Hernández, Michael A. Smith, et al.. (2012). PWE-234 Optimising the response to thiopurine therapy: a search for novel explanations for thiopurine hypermethylation. Gut. 61(Suppl 2). A393.1–A393. 2 indexed citations
12.
Smith, Melissa, Paul Blaker, Chandan Patel, et al.. (2012). The impact of introducing thioguanine nucleotide monitoring into an inflammatory bowel disease clinic. International Journal of Clinical Practice. 67(2). 161–169. 46 indexed citations
13.
Blaker, Paul, Monica Arenas-Hernandez, Anthony M. Marinaki, & Jeremy Sanderson. (2012). The Pharmacogenetic Basis of Individual Variation in Thiopurine Metabolism. Personalized Medicine. 9(7). 707–725. 13 indexed citations
14.
Blaker, Paul, M Arenas, L. D. Fairbanks, et al.. (2011). A biochemical mechanism for the role of allopurinol in TMPT inhibition. Gut. 60(Suppl 1). A132.2–A133. 3 indexed citations
15.
Blaker, Paul, et al.. (2011). Long term experience using tenofovir and entecavir in the management of chronic hepatitis B in teaching hospital practice. Gut. 60(Suppl 1). A226.1–A226. 1 indexed citations
16.
Blaker, Paul & Mark D. Wilkinson. (2010). Chronic constipation: diagnosis and current treatment options. Prescriber. 21(9). 30–45. 5 indexed citations
17.
Chaplin, Steve, Paul Blaker, & Mark D. Wilkinson. (2010). Prucalopride (Resolor): new treatment for chronic constipation. Prescriber. 21(11). 24–29. 5 indexed citations
18.
19.
Sadideen, Hazim, Paul Blaker, Patrick O’Donnell, John L. Taylor, & David Goldsmith. (2008). Tuberculosis complicating tertiary hyperparathyroidism in a patient with end-stage renal disease: a case report. Journal of Nephrology. 21(3). 438–441. 7 indexed citations
20.
Kapoor, Raju, Meirion Davies, Paul Blaker, Susan Hall, & Kenneth J. Smith. (2002). Blockers of sodium and calcium entry protect axons from nitric oxide‐mediated degeneration. Annals of Neurology. 53(2). 174–180. 189 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by ANNE M. V. BROOKS Breakdown of academic impact, for papers by Gary Tye Breakdown of academic impact, for papers by Amnon Cohen Breakdown of academic impact, for papers by M. P. Fondelli Breakdown of academic impact, for papers by L. Teerenhovi Breakdown of academic impact, for papers by N. Matheis Breakdown of academic impact, for papers by Haruo Tamaki Breakdown of academic impact, for papers by NORIO YOSHIKAWA Breakdown of academic impact, for papers by Hamed Esfandiari Breakdown of academic impact, for papers by N. Gombakis
Rankless by CCL
2026